ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder
NCT00613067
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Generalized Anxiety Disorder
Interventions
DRUG:
escitalopram
Sponsor
Inje University